Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 168.5B | 142.2B | 159.4B | 131.7B |
Cost of revenue | — | 29.0B | 52.0B | — |
Gross profit | 168.5B | 113.2B | 107.4B | 131.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 156.2B | 58.2B | 53.1B | 128.0B |
Other operating expenses | — | 1.4B | 518.9M | -127.3M |
Operating income | 168.5B | 11.2B | 12.2B | 3.8B |
Non operating interest income | ||||
Income | — | 1.9B | 1.9B | 2.2B |
Expense | — | 560.7M | 603.3M | 614.0M |
Other income expense | — | — | — | — |
Pretax income | 15.3B | 16.7B | 14.5B | 12.8B |
Tax provision | 1.2B | -1.8B | 941.7M | 163.1M |
Net income | 14.4B | 48.7B | 13.6B | 12.6B |
Basic EPS | 766.4 | — | 736 | 557 |
Diluted EPS | 766.4 | — | 736 | 557 |
Basic average shares | — | — | 15.5M | 15.5M |
Diluted average shares | — | — | 15.5M | 15.5M |
EBITDA | 168.5B | 22.1B | 22.1B | 15.7B |
Net income from continuing op. | — | 48.7B | 13.6B | 12.6B |
Minority interests | -2.5B | -8.6B | -2.2B | -4.0B |
Preferred stock dividends | — | — | — | — |